Novel Redox-Responsive Polymeric Magnetosomes with Tunable Magnetic Resonance Property for In Vivo Drug Release Visualization and Dual-Modal Cancer Therapy

Zhongling Wang, Xiangdong Xue, Yixuan He, Ziwei Lu, Bei Jia, Hao Wu, Ye Yuan, Yee Huang, Han Wang, Hongwei Lu, Kit Lam, Tzu-Yin Lin, Yuanpei Li

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Monitoring of in vivo drug release from nanotheranostics by noninvasive approaches remains very challenging. Herein, novel redox-responsive polymeric magnetosomes (PolyMags) with tunable magnetic resonance imaging (MRI) properties are reported for in vivo drug release monitoring and effective dual-modal cancer therapy. The encapsulation of doxorubicin (DOX) significantly decreases PolyMags' T2-contrast enhancement and transverse relaxation rate R2, depending on the drug loading level. The T2 enhancement and R2 can be recovered once the drug is released upon PolyMags' disassembly. T2- and T2*-MRI and diffusion-weighted imaging (DWI) are utilized to quantitatively study the correlation between MRI signal changes and drug release, and discover the MR tuning mechanisms. The in vivo drug release pattern is visualized based on such tunable MRI capability via monitoring the changes in T2-weighted images, T2 and T2* maps, and R2 and R2* values. Interestingly, the PolyMags possess excellent photothermal effect, which can be further enhanced upon DOX loading. The PolyMags are highly efficacious to treat breast tumors on xenograft model with tumor-targeted photothermal- and chemotherapy, achieving a complete cure rate of 66.7%. The concept reported here is generally applicable to other micellar and liposomal systems for image-guided drug delivery and release applications toward precision cancer therapy.

Original languageEnglish (US)
Article number1802159
JournalAdvanced Functional Materials
Volume28
Issue number33
DOIs
StatePublished - Aug 15 2018

Fingerprint

Magnetic resonance
magnetic resonance
therapy
drugs
Visualization
cancer
Imaging techniques
Pharmaceutical Preparations
Monitoring
Tumors
Doxorubicin
Chemotherapy
tumors
Drug delivery
Encapsulation
augmentation
Heterografts
Tuning
chemotherapy
Oxidation-Reduction

Keywords

  • cancer therapy
  • drug release
  • magnetic resonance imaging
  • nanoparticles

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Condensed Matter Physics
  • Electrochemistry

Cite this

Novel Redox-Responsive Polymeric Magnetosomes with Tunable Magnetic Resonance Property for In Vivo Drug Release Visualization and Dual-Modal Cancer Therapy. / Wang, Zhongling; Xue, Xiangdong; He, Yixuan; Lu, Ziwei; Jia, Bei; Wu, Hao; Yuan, Ye; Huang, Yee; Wang, Han; Lu, Hongwei; Lam, Kit; Lin, Tzu-Yin; Li, Yuanpei.

In: Advanced Functional Materials, Vol. 28, No. 33, 1802159, 15.08.2018.

Research output: Contribution to journalArticle

Wang, Zhongling ; Xue, Xiangdong ; He, Yixuan ; Lu, Ziwei ; Jia, Bei ; Wu, Hao ; Yuan, Ye ; Huang, Yee ; Wang, Han ; Lu, Hongwei ; Lam, Kit ; Lin, Tzu-Yin ; Li, Yuanpei. / Novel Redox-Responsive Polymeric Magnetosomes with Tunable Magnetic Resonance Property for In Vivo Drug Release Visualization and Dual-Modal Cancer Therapy. In: Advanced Functional Materials. 2018 ; Vol. 28, No. 33.
@article{c8246df6d58440dcb4ed61ea81b265f0,
title = "Novel Redox-Responsive Polymeric Magnetosomes with Tunable Magnetic Resonance Property for In Vivo Drug Release Visualization and Dual-Modal Cancer Therapy",
abstract = "Monitoring of in vivo drug release from nanotheranostics by noninvasive approaches remains very challenging. Herein, novel redox-responsive polymeric magnetosomes (PolyMags) with tunable magnetic resonance imaging (MRI) properties are reported for in vivo drug release monitoring and effective dual-modal cancer therapy. The encapsulation of doxorubicin (DOX) significantly decreases PolyMags' T2-contrast enhancement and transverse relaxation rate R2, depending on the drug loading level. The T2 enhancement and R2 can be recovered once the drug is released upon PolyMags' disassembly. T2- and T2*-MRI and diffusion-weighted imaging (DWI) are utilized to quantitatively study the correlation between MRI signal changes and drug release, and discover the MR tuning mechanisms. The in vivo drug release pattern is visualized based on such tunable MRI capability via monitoring the changes in T2-weighted images, T2 and T2* maps, and R2 and R2* values. Interestingly, the PolyMags possess excellent photothermal effect, which can be further enhanced upon DOX loading. The PolyMags are highly efficacious to treat breast tumors on xenograft model with tumor-targeted photothermal- and chemotherapy, achieving a complete cure rate of 66.7{\%}. The concept reported here is generally applicable to other micellar and liposomal systems for image-guided drug delivery and release applications toward precision cancer therapy.",
keywords = "cancer therapy, drug release, magnetic resonance imaging, nanoparticles",
author = "Zhongling Wang and Xiangdong Xue and Yixuan He and Ziwei Lu and Bei Jia and Hao Wu and Ye Yuan and Yee Huang and Han Wang and Hongwei Lu and Kit Lam and Tzu-Yin Lin and Yuanpei Li",
year = "2018",
month = "8",
day = "15",
doi = "10.1002/adfm.201802159",
language = "English (US)",
volume = "28",
journal = "Advanced Materials for Optics and Electronics",
issn = "1057-9257",
publisher = "Wiley-VCH Verlag",
number = "33",

}

TY - JOUR

T1 - Novel Redox-Responsive Polymeric Magnetosomes with Tunable Magnetic Resonance Property for In Vivo Drug Release Visualization and Dual-Modal Cancer Therapy

AU - Wang, Zhongling

AU - Xue, Xiangdong

AU - He, Yixuan

AU - Lu, Ziwei

AU - Jia, Bei

AU - Wu, Hao

AU - Yuan, Ye

AU - Huang, Yee

AU - Wang, Han

AU - Lu, Hongwei

AU - Lam, Kit

AU - Lin, Tzu-Yin

AU - Li, Yuanpei

PY - 2018/8/15

Y1 - 2018/8/15

N2 - Monitoring of in vivo drug release from nanotheranostics by noninvasive approaches remains very challenging. Herein, novel redox-responsive polymeric magnetosomes (PolyMags) with tunable magnetic resonance imaging (MRI) properties are reported for in vivo drug release monitoring and effective dual-modal cancer therapy. The encapsulation of doxorubicin (DOX) significantly decreases PolyMags' T2-contrast enhancement and transverse relaxation rate R2, depending on the drug loading level. The T2 enhancement and R2 can be recovered once the drug is released upon PolyMags' disassembly. T2- and T2*-MRI and diffusion-weighted imaging (DWI) are utilized to quantitatively study the correlation between MRI signal changes and drug release, and discover the MR tuning mechanisms. The in vivo drug release pattern is visualized based on such tunable MRI capability via monitoring the changes in T2-weighted images, T2 and T2* maps, and R2 and R2* values. Interestingly, the PolyMags possess excellent photothermal effect, which can be further enhanced upon DOX loading. The PolyMags are highly efficacious to treat breast tumors on xenograft model with tumor-targeted photothermal- and chemotherapy, achieving a complete cure rate of 66.7%. The concept reported here is generally applicable to other micellar and liposomal systems for image-guided drug delivery and release applications toward precision cancer therapy.

AB - Monitoring of in vivo drug release from nanotheranostics by noninvasive approaches remains very challenging. Herein, novel redox-responsive polymeric magnetosomes (PolyMags) with tunable magnetic resonance imaging (MRI) properties are reported for in vivo drug release monitoring and effective dual-modal cancer therapy. The encapsulation of doxorubicin (DOX) significantly decreases PolyMags' T2-contrast enhancement and transverse relaxation rate R2, depending on the drug loading level. The T2 enhancement and R2 can be recovered once the drug is released upon PolyMags' disassembly. T2- and T2*-MRI and diffusion-weighted imaging (DWI) are utilized to quantitatively study the correlation between MRI signal changes and drug release, and discover the MR tuning mechanisms. The in vivo drug release pattern is visualized based on such tunable MRI capability via monitoring the changes in T2-weighted images, T2 and T2* maps, and R2 and R2* values. Interestingly, the PolyMags possess excellent photothermal effect, which can be further enhanced upon DOX loading. The PolyMags are highly efficacious to treat breast tumors on xenograft model with tumor-targeted photothermal- and chemotherapy, achieving a complete cure rate of 66.7%. The concept reported here is generally applicable to other micellar and liposomal systems for image-guided drug delivery and release applications toward precision cancer therapy.

KW - cancer therapy

KW - drug release

KW - magnetic resonance imaging

KW - nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85051282647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051282647&partnerID=8YFLogxK

U2 - 10.1002/adfm.201802159

DO - 10.1002/adfm.201802159

M3 - Article

VL - 28

JO - Advanced Materials for Optics and Electronics

JF - Advanced Materials for Optics and Electronics

SN - 1057-9257

IS - 33

M1 - 1802159

ER -